Difference between revisions of "Team:Manchester-Graz/Attributions"
MagdalenaHK (Talk | contribs) |
|||
Line 46: | Line 46: | ||
<li>Maria Imran: Project planning, modeling, human practices</li> | <li>Maria Imran: Project planning, modeling, human practices</li> | ||
</ul> | </ul> | ||
− | + | <br><br> | |
<h2>General Support</h2> | <h2>General Support</h2> | ||
<ul style="font-size:16px;"> | <ul style="font-size:16px;"> | ||
Line 60: | Line 60: | ||
<li>Alexander Wood: supervision, lab help, HPLC expert</li> | <li>Alexander Wood: supervision, lab help, HPLC expert</li> | ||
<li>Nicholas Weise: supervision, lab help , HPLC expert</li> | <li>Nicholas Weise: supervision, lab help , HPLC expert</li> | ||
− | <li>Robert Harrison: | + | <li>Robert Harrison: human practices expert</li> |
− | <li>Dr. Peter Both | + | <li>Dr. Peter Both: gene and vector design</li> |
− | + | <li>Rehana: LCMS expert, explained the use of HPLC in our project</li> | |
− | + | ||
− | <li>Rehana | + | |
− | + | ||
</ul> | </ul> | ||
Line 74: | Line 71: | ||
<ul style="font-size:16px;"> | <ul style="font-size:16px;"> | ||
<li>Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background</li> | <li>Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background</li> | ||
− | <li>Dr. Christoph Högenauer: Discussion about treatment of Parkinson patients, feasibility and possible application of the DopaDoser | + | <li>Dr. Christoph Högenauer: Discussion about treatment of Parkinson's patients, feasibility and possible application of the DopaDoser |
Modeling Support</li> | Modeling Support</li> | ||
− | <li>Dr. Monty Silverdale: interview | + | <li>Dr. Monty Silverdale: Parkinson's consultant, interview about the feasibility of our project</li> |
<li>Prof Dr. Angela Tod: interview </li> | <li>Prof Dr. Angela Tod: interview </li> | ||
− | <li>Julia: | + | <li>Julia: Parkinson's patient who helped us understand the disease and treatments from a patient's perspective</li> |
− | <li>Dr. Andy Balmer: | + | <li>Dr. Andy Balmer: introduced us to human practices and gave us feedback on project feasibility</li> |
− | <li>Dr. Mariella Kögl-wallner: interview about | + | <li>Dr. Mariella Kögl-wallner: interview about Parkinson's disease from a neurological point of view</li> |
− | <li>Walter: | + | <li>Walter: Parkinson's patient</li> |
</ul> | </ul> | ||
Line 90: | Line 87: | ||
<li>Areti Tsigkinopoulou: Supported the model developing process of a quorum sensing system, general Matlab and Simbiology support</li> | <li>Areti Tsigkinopoulou: Supported the model developing process of a quorum sensing system, general Matlab and Simbiology support</li> | ||
<li>Dr Neil Swainston: introducing MatLab, explaining Flux Balance Analysis modeling and guiding us throughout the project on modeling</li> | <li>Dr Neil Swainston: introducing MatLab, explaining Flux Balance Analysis modeling and guiding us throughout the project on modeling</li> | ||
+ | <li>Dr Jean-Marc Schwartz: Modelling support with Flux Balance Analysis</li> | ||
</ul> | </ul> | ||
Revision as of 03:09, 10 September 2015
Attributions
Team
- Christoph Schilling: Vector design and development, lab work
- Iaroslav Kosov: Human practices, project planning, modelling
- Martin Senekowitsch: Wiki design and development, project funding, lab work, human practices
- Magdalena Hannah Kurteu: Project funding, lab work, human practices
- Kerstin Stadler: Project funding, project planning, lab work, human practices
- Aaron Gretton: Project funding, human practices, modelling
- Peter Kusstatscher: Modeling, project planning, graphic design, lab work
- Priyanshu Sinha: Project planning, lab work, modeling
- Markus Hobisch: Lab work, project planning, human practices
- Rachel Stirrup: Project planning, lab work, human practices
- Melanie Ballach: Project planning, lab work
- Maria Imran: Project planning, modeling, human practices
General Support
- Prof. Dr. Anton Glieder: Supervision of Team Graz, organizational work
- Prof. Dr. Christoph Sensen: general support regarding organizational work and social media
- Dr. Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work
- Christian Schmid: helped us with organization and shipment of products from our sponsors
- Dr. Birgit Wiltschi: helped us with our Vector Design and gave general support during the vector assembly process
- Prof Dr. Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision
- Prof Dr. Reiner Breitling: modeling advisor, supervision
- Prof Dr. Sabine Flitsch: supervision, inter-European team idea organizer, gut bacteria idea, PD patient interview organizer
- Lorna Hepworth: supervision, new techniques explanation
- Alexander Wood: supervision, lab help, HPLC expert
- Nicholas Weise: supervision, lab help , HPLC expert
- Robert Harrison: human practices expert
- Dr. Peter Both: gene and vector design
- Rehana: LCMS expert, explained the use of HPLC in our project
Human Practices
- Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background
- Dr. Christoph Högenauer: Discussion about treatment of Parkinson's patients, feasibility and possible application of the DopaDoser Modeling Support
- Dr. Monty Silverdale: Parkinson's consultant, interview about the feasibility of our project
- Prof Dr. Angela Tod: interview
- Julia: Parkinson's patient who helped us understand the disease and treatments from a patient's perspective
- Dr. Andy Balmer: introduced us to human practices and gave us feedback on project feasibility
- Dr. Mariella Kögl-wallner: interview about Parkinson's disease from a neurological point of view
- Walter: Parkinson's patient
Modeling
- Areti Tsigkinopoulou: Supported the model developing process of a quorum sensing system, general Matlab and Simbiology support
- Dr Neil Swainston: introducing MatLab, explaining Flux Balance Analysis modeling and guiding us throughout the project on modeling
- Dr Jean-Marc Schwartz: Modelling support with Flux Balance Analysis
Special Thank You to our sponsors!
- University of Technology Graz
- The University of Manchester
- Sanofiy
- Evolva
- IBCarb Network
- Integrated DNA Technologies
- Bartelt
- Lactan
- Microsynth
- Qiagen
- New England BioLabs Inc.
- ThermoFisher Scientific
- VWR International
- Ardeypharm
- SnapGene
- Sigma-Aldrich
- Promega
- SMB Industrieanlagenbau GmbH
- Merck Millipore